Antitumor effects of interleukin-2 gene-modified fibroblasts in an orthotopic colon cancer model

Japanese Journal of Cancer Research

Volumn 90, Issue 9, 1999, Pages 1000-1006

  Terasawa, Hiroshi ^a   Tanimura, Hiroshi ^a   Nakamori, Mikihito ^a   Tsunoda, Takuya ^a   Iwahashi, Makoto ^a   Tani, Masaji ^a   Yamaue, Hiroki ^a  

^a WAKAYAMA MEDICAL UNIVERSITY   (Japan)

Author keywords

Cytokine gene; Fibroblast; Gene therapy; Orthotopic model

Indexed keywords

BLOCKING ANTIBODY; CD8 ANTIGEN; GANGLIOTETRAOSYLCERAMIDE; GENE PRODUCT; INTERLEUKIN 2; VIRUS VECTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER CELL CULTURE; CANCER INHIBITION; CANCER TRANSPLANTATION; CECUM TUMOR; COLON CANCER; CONTROLLED STUDY; CYTOKINE RELEASE; CYTOTOXICITY; FEMALE; FIBROBLAST; GENETIC TRANSDUCTION; KILLER CELL; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; SPLEEN CELL;

EID: 0032709514     PISSN: 09105050     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1349-7006.1999.tb00848.x     Document Type: Article

References (25)

1. Gansbacher, B., Zier, K., Daniels, B., Cronin, K., Bannerji, R. and Gilboa, E. Interleukin 2 gene transfer into tumor cells abrogates tumorigenicity and induces protective immunity. J. Exp. Med., 172, 1217-1224 (1990).
2. Fearon, E. R., Pardoll, D. M., Itaya, T., Golumbek, P., Levitsky, H. I., Simons, J. W., Karasuyama, H., Vogelstein, B. and Frost, P. Interleukin-2 production by tumor cells bypasses T helper function in the generation of an antitumor response. Cell, 60, 397-403 (1990).
3. Conne, J., Bannerji, R., Saito, S., Heston, W., Fair, W. and Gilboa, E. Regression of bladder tumors in mice treated with interleukin-2 gene-modified tumor cells. J. Exp. Med., 177, 1127-1134 (1993).
4. Yannelli, J. R., Hyatt, C., Johnson, S., Hwu, P. and Rosenberg, S. A. Characterization of human tumor cell lines transduced with the cDNA encoding either TNF-α or IL-2. J. Immunol. Methods, 161, 77-90 (1993).
5. Veelken, H., Jesuiter, H., Mackensen. A., Kulmburg, P., Schultze, J., Rosenthal, F., Mertelsmann, R. and Lindemann, A. Primary fibroblasts from human adults as target cells for ex vivo transfection and gene therapy. Human Gene Ther., 5, 1203-1210 (1994).
6. Elder, E. M., Lotze, M. T. and Whiteside, T. L. Successful culture and selection of cytokine gene-modified human dermal fibroblasts for the biologic therapy of patients with cancer. Human Gene Ther., 7, 479-487 (1996).
7. Kim, T. S. and Cohen, E. P. Immunization of mice with allogenic fibroblasts genetically modified for interleukin-2-secretion and expression of melanoma-associated antigens stimulate predetermined classes of anti-melanoma effector cells. J. Immunother., 16, 24-35 (1994).
8. Tahara, H., Zeh, H. J., III, Storkus, W. J., Pappo, I., Watkins, S. C., Gubler, U., Gubler, S. F., Robbins, P. D. and Lotze, M. T. Fibroblasts genetically engineered to secrete interleukin-12 can suppress tumor growth and induce antitumor immunity to a murine melanoma in vivo. Cancer Res., 54, 182-189 (1994).
9. Glick, R. P., Lichtor, T., Kim, T. S., Ilangovan, S. and Cohen, E. P. Fibroblasts genetically engineered to secrete cytokines suppress tumor growth and induce antitumor immunity to a murine glioma in vivo. Neurosurgety, 36, 548-555 (1995).
10. Shawler, D. L., Dorigo, O., Gjerset, R. A., Royston, I., Sobol, R. E. and Fakhrai, H. Comparison of gene therapy with interleukin-2 gene modified fibroblasts and tumor cells in the murine CT26 model of colorectal carcinoma. J. Immunother., 17, 201-208 (1995).
11. Fu, X., Besterman, J. M., Monosov, A. and Hoffman, R. M. Models of human metastatic colon cancer in nude mice orthotopically constructed by using histologically intact patient specimens. Proc. Natl. Acad. Sci. USA, 88, 9345-9349 (1991).
12. Fu, X., Guadagni, F. and Hoffman, R. M. A metastatic nude-mouse model of human pancreatic cancer constructed orthotopically with histologically intact patient specimens. Proc. Natl. Acad. Sci. USA, 89, 5645-5649 (1992).
13. Brattain, M. G., Strobel-Stevens, J., Fine, D., Webb, M. and Sarrif, A. M. Established mouse colonic carcinoma cell lines with different metastatic properties. Cancer Res., 40, 2142-2146 (1980).
14. Miller, A. D. and Rosman, G. J. Improved retroviral vectors for gene transfer and expression. Biotechniques, 7, 980-990 (1989).
15. Yamaue, H., Kasshmiri, S. V. S., Fillipi, R. D., Nieroda, C., Yannelli, J. R., Tsang, K. Y. and Schlom, J. Enhanced interleukin-2 production in human tumor-infiltrating lymphocytes engineered by 3′-truncated interleukin-2 gene. J. Immunother., 16, 262-274 (1994).
16. Mann, R., Mulligan, R. C. and Baltimore, D. Construction of a retrovirus packaging mutant and its use to produce helper-free defective retrovirus. Cell, 33, 153-159 (1983).
17. Miller, A. D. and Buttimore, C. Redesign of retrovirus packaging cell lines to avoid recombination leading to helper virus production. Mol. Cell. Biol., 6, 2895-2902 (1986).
18. Feigner, P. L., Gadek. T. R., Holm, M., Roman, R., Chan, H. W., Wenz, M., Northrop, J. P., Ringold, G. M. and Danielsen, M. Lipofection: a highly efficient, lipid-mediated DNA transfection procedure. Proc. Natl. Acad. Sci. USA, 84, 7413-7417 (1987).
19. Kozak, S. L. and Kabat, D. Ping-pong amplification of a retroviral vector achieves high-level gene expression. J. Virol., 64, 3500-3508 (1990).
20. Yamaue, H., Tanimura, H., Iwahashi, M., Tani. M., Tsunoda, T., Tabuse, K., Kuribayashi, K. and Saito, K. Role of IL-2 and IFN-γ in induction of activated natural killer cells from mice primed in vivo and subsequently challenged in vitro with the streptococcal preparation of OK432. Cancer Immunol. Immunother., 29, 79-86 (1989).
21. Ragg, S. J., Dandie, G. W., Woods, G. M. and Muller, H. K. Dendritic cells migrating from carcinogen-treated skin have reduced antigen-presenting function. Adv. Exp. Med. Biol., 2, 237-241 (1995).
22. Ribas, A., Butterfield, L. H., McBride, W. H., Jilani, S. M., Bui, L. A., Vollmer, C. M., Lau, R., Dissette, V. B., Hu, B., Chen, A. Y., Glaspy, J. A. and Economou, J. S. Genetic immunization for the melanoma antigen MART/Melan-A using recombinant adenovirus-transduced murine dendritic cells. Cancer Res., 57, 2865-2869 (1997).
23. Chen, S.-H., Kosai, K., Xu, B., Pham-Nguyen, K., Contant, C., Finegold, M. J. and Woo, S. L. C. Combination suicide and cytokine gene therapy for hepatic metastasis of colon carcinoma: sustained antitumor immunity prolongs animal survival. Cancer Res., 56, 3758-3762 (1996).
24. Fujimoto-Ouchi, K., Tamura, S., Mon, K., Tanaka, Y. and Ishitsuka, H. Establishment and characterization of cachexia-inducing and noninducing clones of murine colon 26 carcinoma. Int. J. Cancer, 61, 522-528 (1995).
25. Fakhrai, H., Shawler, D. L., Gjerset, R., Naviaux, R. K., Koziol, J., Royston, I. and Sobol, R. E. Cytokine gene therapy with interleukin-2-transduced fibroblasts: effects of IL-2 dose on anti-tumor immunity. Human Gene Ther., 6, 591-601 (1995).